Bank Of New York Mellon Corp Graybug Vision, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.05 $46,103 - $105,237	100,226 New	100,226 $50,000
Q2 2022 Aug 15, 2022	SELL	$0.76 - $1.25 $505 - $831	-665 Reduced 0.65%	100,981 $110,000
Q1 2022 May 11, 2022	BUY	$1.13 - $1.93 $94,245 - $160,967	83,403 Added 457.18%	101,646 $125,000
Q1 2021 May 13, 2021	BUY	$5.55 - $35.0 $10,661 - $67,235	1,921 Added 11.77%	18,243 $101,000
Q4 2020 Feb 09, 2021	BUY	$13.05 - $33.93 $213,002 - $553,805	16,322 New	16,322 $473,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.